2 tracked superinvestors hold 10X Genomics Inc (TXG), worth $399M combined, led by Cathie Wood. Smart money is holding TXG as of the latest 13F filings.
Current price
$62.65
+361.7%
1Y
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering…
Market cap
$2.9B
P/E
-64.09
Div yield
0.0%
Revenue YoY
5.2%
Analyst target
$49
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
2
tracked 13F / N-PORT funds
Combined value
$399M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
0
1 buying · 1 selling
Smart money is holding TXG steady this quarter — buys and sells are balanced. 1 opened a brand-new position.
10X Genomics Inc (TXG) is held by 2 tracked funds worth $399M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Cathie Wood at 2.5% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
This quarter 1 fund opened a brand-new position (Stanley Druckenmiller), with 0 adding and 1 trimming — a net accumulation signal.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Trimmed | 2.5% | $384M | |
| New buy | 0.3% | $15M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
5 insiders filed SEC Form 144 for $7M of proposed sales in the last 90 days. A 144 is filed before the trade — see who else is selling.
| Insider | Role | Shares | Value | Filed |
|---|---|---|---|---|
| Adam Taich | Officer | 46,388 | $3M | 2026-09-09 |
| Stuelpnagel John R | Director | 20,000 | $1M | 2026-09-03 |
| Saxonov Serge | Officer & Director | 17,948 | $1M | 2026-08-24 |
| Taich Adam | Officer | 16,614 | $1M | 2026-08-24 |
| Hindson Benjamin J. | Officer & Director | 13,373 | $871K | 2026-08-24 |
Which superinvestors own TXG?
2 tracked funds hold 10X Genomics Inc (TXG), the largest being Cathie Wood (ARK Invest) at 2.5% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling TXG?
In the most recent 13F quarter, 1 tracked fund added or opened TXG and 1 trimmed it, including 1 brand-new position.
How much TXG do tracked funds hold?
Combined disclosed long exposure to TXG across tracked superinvestors is $399M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.